CNN: Drug company faked cancer patients to sell drug
In 2012, drug maker Insys Therapeutics received approval to sell an “ultra-powerful” opioid (a sprayable form of fentanyl called Subsys) for cancer patients with acute pain but quickly realized that the market for their drug was thin. So, according to a federal indictment and ongoing congressional investigation by Senator Claire McCaskill (D- Missouri), they simply created patients who needed their drug. They did so by “falsifying medical records, misleading insurance companies, and providing kickbacks to doctors in league with the company.” 1 “Because of the high cost associated with Subsys, most insurers wouldn’t pay for it unless it was approved in...
Read More






